Papers
2
Total Citations
57
H-Index
2
About
Kris E. Gaston is a leading urologic oncologist whose research centers on improving surgical outcomes for bladder cancer patients, particularly through the refinement of robot-assisted techniques. His most impactful contribution is a landmark 2010 study demonstrating that robot-assisted extended pelvic lymphadenectomy during radical cystectomy yields lymph node counts comparable to open surgery, with a second-look dissection confirming completeness. This work, cited 55 times, helped validate the oncologic adequacy of minimally invasive approaches for muscle-invasive bladder cancer. Gaston’s research also addresses postoperative complications, as shown in his 2019 investigation of ureteral stent urine cultures following ileal conduit diversion. This study revealed that positive stent cultures strongly predict urinary tract infection-related readmissions, offering a practical tool for reducing hospital returns. With a career focused on merging technical innovation with patient-centered outcomes, Gaston has advanced the evidence base for robotic cystectomy while tackling real-world challenges like infection prevention. His work continues to influence urologic oncology practice, guiding surgeons in optimizing both cancer control and recovery quality.
Research Focus
Key Achievements
Top Papers
- 1
- 2